- Home
- BHIL vs ALLR Comparison
BHIL vs ALLR Comparison
Compare BHIL & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHIL
- ALLR
- Stock Information
- Founded
- BHIL 2012
- ALLR 2004
- Country
- BHIL United States
- ALLR United States
- Employees
- BHIL N/A
- ALLR N/A
- Industry
- BHIL Packaged Foods
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- BHIL Consumer Staples
- ALLR Health Care
- Exchange
- BHIL Nasdaq
- ALLR Nasdaq
- Market Cap
- BHIL 5.1M
- ALLR 4.7M
- IPO Year
- BHIL N/A
- ALLR N/A
- Fundamental
- Price
- BHIL $0.78
- ALLR $0.90
- Analyst Decision
- BHIL
- ALLR
- Analyst Count
- BHIL 0
- ALLR 0
- Target Price
- BHIL N/A
- ALLR N/A
- AVG Volume (30 Days)
- BHIL 99.4K
- ALLR 2.4M
- Earning Date
- BHIL 05-08-2025
- ALLR 03-25-2025
- Dividend Yield
- BHIL N/A
- ALLR N/A
- EPS Growth
- BHIL N/A
- ALLR N/A
- EPS
- BHIL N/A
- ALLR N/A
- Revenue
- BHIL $466,725,000.00
- ALLR N/A
- Revenue This Year
- BHIL N/A
- ALLR N/A
- Revenue Next Year
- BHIL N/A
- ALLR N/A
- P/E Ratio
- BHIL N/A
- ALLR N/A
- Revenue Growth
- BHIL 139.60
- ALLR N/A
- 52 Week Low
- BHIL $0.73
- ALLR $0.68
- 52 Week High
- BHIL $11.03
- ALLR $231.00
- Technical
- Relative Strength Index (RSI)
- BHIL 37.11
- ALLR 44.17
- Support Level
- BHIL $0.80
- ALLR $1.00
- Resistance Level
- BHIL $1.32
- ALLR $1.24
- Average True Range (ATR)
- BHIL 0.11
- ALLR 0.14
- MACD
- BHIL 0.04
- ALLR 0.02
- Stochastic Oscillator
- BHIL 7.82
- ALLR 40.02
About BHIL Benson Hill Inc.
Benson Hill Inc is an ag-tech company specializing in soy protein innovation. The company has one business segment Ingredient. The company focuses on seed innovation through proprietary germplasm and the CropOS platform. This platform integrates protein, genomic, and strategic data for predictive breeding using AI and ML. They operate a Crop Accelerator for rapid prototyping. Benson Hill is developing a seed portfolio for protein ingredients, aquaculture, specialty animal feed, and vegetable oils. The company's revenue can be disaggregated into product categories: Proprietary and Non-Proprietary. Proprietary revenue is defined as any sale of a proprietary bean. Non-Proprietary revenue is all other revenue from non-Proprietary sources.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.